About US
Contact us
-
AstraZeneca to build production facility in China for COPD inhaler BreztriAstraZeneca plans to build a manufacturing facility in Qingdao, China, to produce its Breztri aerosol inhalant COPD treatment, which was recently added to the country’s National Reimbursement Drug Li2022/7/13
-
Pfizer's blockbuster rare disease med Vyndaqel hits supply snag in Korea thanks to quality problem: reportFollowing recent recalls of blood pressure medicines in North America, Pfizer has run into another drug manufacturing problem—this time in Asia. Pfizer halted the supply of rare disease med Vyn2022/7/13
-
Enhertu's standing ovation; Tessa's $126M CAR-T financing; Samsung's manufacturing dealAstraZeneca and Daiichi Sankyo's Enhertulooked on track to open a new breast cancer category: HER2-low. Singapore's Tessa Therapeutics grabbed $126 million in a series A to advance its CAR-T programs2022/7/11
-
Sanofi union members set strike date in Korea as wage negotiations stall: reportFed up with a low salary increase, unionized Sanofi workers in South Korea have threatened to go on strike. The workers will strike next month after failing to reach an agreement on a new wage2022/7/11
-
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: BloombergFor months, the industry has waited patiently as Novartis mulls the fate of its $25 billion generics arm. Now, it appears a spinoff could be in the cards. Staring down a tough market for a pote2022/7/5
-
Astellas' gene therapy setback and new partnerships; Fujifilm's $1.6B expansionAstellaswas hit with another gene therapy clinical hold, but the Japanese pharma signed two partnerships focused on novel antibody-drug conjugate technology and undruggable targets. Fujifilm is pouri2022/7/5
-
J&J, Legend's new CAR-T data; Junshi's antiviral tops Pfizer's Paxlovid; Vir, WuXi end COVID pactJohnson & Johnson and Legend Biotech further padded the case for their BCMA CAR-T therapy Carvyktiin multiple myeloma. Junshi Biosciences said a China phase 3 trial has found its oral COVID antiv2022/6/30
-
Samsung Biologics ties up with Novartis in $81M contract manufacturing dealSamsung Biologics has signed an initial $81 million contract manufacturing and development deal with Novartis, marking the first time the two companies have worked together. Samsung Biologicsre2022/6/30
-
Sanofi union members set strike date in Korea as wage negotiations stall: reportFed up with a low salary increase, unionized Sanofi workers in South Korea have threatened to go on strike. The workers will strike next month after failing to reach an agreement on a new wage2022/6/28
-
Enhertu's standing ovation; Tessa's $126M CAR-T financing; Samsung's manufacturing dealAstraZeneca and Daiichi Sankyo's Enhertulooked on track to open a new breast cancer category: HER2-low. Singapore's Tessa Therapeutics grabbed $126 million in a series A to advance its CAR-T programs2022/6/28